Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
CVS Health
CVS
|
$747M |
| 2 |
Bank of America
BAC
|
$668M |
| 3 |
Truist Financial
TFC
|
$648M |
| 4 |
VF Corp
VFC
|
$567M |
| 5 |
Fidelity National Information Services
FIS
|
$491M |
Top Sells
| 1 |
VMW
VMware, Inc
VMW
|
$1.05B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$644M |
| 3 |
Capital One
COF
|
$613M |
| 4 |
Cisco
CSCO
|
$608M |
| 5 |
UBS Group
UBS
|
$455M |
Sector Composition
| 1 | Financials | 20.65% |
| 2 | Healthcare | 19.58% |
| 3 | Technology | 15.74% |
| 4 | Communication Services | 12.93% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GE HealthCare
GEHC
$33.7B
| $1.17B | 0.79% | 17,132,992 -172,432 | -1% | -$11.7M |
|
|
JNPR
52
DELISTED
Juniper Networks
JNPR
| $965M | 0.65% | 34,712,980 -270,550 | -0.8% | -$7.52M |
|
53
Hewlett Packard
HPE
$29.6B
| $951M | 0.64% | 54,750,973 -532,450 | -1% | -$9.25M |
|
54
Incyte
INCY
$16.5B
| $948M | 0.64% | 16,416,111 -2,861,849 | -15% | -$165M |
|
55
Elanco Animal Health
ELAN
$9.12B
| $946M | 0.64% | 84,203,300 -418,050 | -0.5% | -$4.7M |
|
56
Bristol-Myers Squibb
BMY
$96B
| $942M | 0.63% | 16,233,108 -171,238 | -1% | -$9.94M |
|
57
Fox Class A
FOXA
$26.6B
| $937M | 0.63% | 30,041,880 -8,657,381 | -22% | -$270M |
|
58
Molson Coors Class B
TAP
$9.98B
| $934M | 0.63% | 14,688,664 -3,464,810 | -19% | -$220M |
|
59
HP
HPQ
$26.7B
| $920M | 0.62% | 35,784,082 -3,725,016 | -9% | -$95.7M |
|
60
Haleon
HLN
$43.9B
| $911M | 0.61% | 109,397,859 -1,229,035 | -1% | -$10.2M |
|
61
Celanese
CE
$5.22B
| $873M | 0.59% | 6,955,237 -62,450 | -0.9% | -$7.84M |
|
62
Carrier Global
CARR
$55.5B
| $801M | 0.54% | 14,505,956 -157,225 | -1% | -$8.68M |
|
63
Teck Resources
TECK
$16.7B
| $798M | 0.54% | 18,511,240 -1,253,800 | -6% | -$54M |
|
64
Dell
DELL
$82.6B
| $756M | 0.51% | 10,974,166 -5,589,792 | -34% | -$385M |
|
65
Dominion Energy
D
$51.1B
| $729M | 0.49% | 16,328,283 +899,175 | +6% | +$40.2M |
|
66
Nutrien
NTR
$28B
| $713M | 0.48% | 11,550,359 -21,700 | -0.2% | -$1.34M |
|
67
XP
XP
$9.56B
| $698M | 0.47% | 30,280,445 -4,125,676 | -12% | -$95.1M |
|
68
Credicorp
BAP
$20.4B
| $694M | 0.47% | 5,425,162 +24,731 | +0.5% | +$3.16M |
|
69
Alnylam Pharmaceuticals
ALNY
$58.5B
| $664M | 0.45% | 3,747,155 -42,370 | -1% | -$7.5M |
|
70
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
$24B
| $618M | 0.42% | 14,295,756 -3,062 | -0% | -$132K |
|
71
Coherent
COHR
$14.1B
| $611M | 0.41% | 18,727,789 -1,193,831 | -6% | -$39M |
|
72
Aegon
AEG
$12.3B
| $603M | 0.41% | 125,535,817 -480,329 | -0.4% | -$2.31M |
|
|
73
VF Corp
VFC
$5.91B
| $567M | 0.38% | +32,115,750 | New | +$567M |
|
74
Zimmer Biomet
ZBH
$21B
| $542M | 0.37% | 4,826,725 -37,775 | -0.8% | -$4.24M |
|
75
Medtronic
MDT
$119B
| $538M | 0.36% | 6,864,405 -166,685 | -2% | -$13.1M |
|